Description / Scope of Work
The Nawaz Sharif Institute of Cancer Treatment and Research in Lahore, Punjab is seeking qualified bidders for a framework contract for the procurement of antibiotics for the financial year 2025-26. This tender, referenced as Tender No. 32-26, covers the supply of various antibiotic medications required to support the institute's cancer treatment and research operations. The framework contract will establish terms and conditions for the supply of essential pharmaceutical products, with quantities and specifications detailed in the schedule of requirements provided within the bidding documents.
Eligible bidders must be registered pharmaceutical suppliers or manufacturers authorized to supply antibiotics in Pakistan. Bidders are required to submit valid business registration certificates, manufacturing or distribution licenses, tax clearance certificates, and proof of previous relevant experience supplying medical and pharmaceutical goods. A bid security in the form of a bank guarantee or similar instrument must accompany each bid as specified in the bid data sheet. All bids must be submitted in the prescribed format using the electronic bidding system (e-PADS) and must comply with all technical specifications and terms outlined in the contract documents.
Bidders can obtain complete bidding documents from the Nawaz Sharif Institute of Cancer Treatment and Research, Lahore. Bids must be submitted electronically through the e-PADS portal by the closing date of June 16, 2026. The bid opening will be conducted on the same date by the procuring agency. Bidders should direct clarifications and inquiries to the institute's procurement department. All submissions must include required certifications, technical compliance documents, and financial bids in the format specified in the instructions to bidders section of the tender documentation.